{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:42:33Z","timestamp":1774453353117,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":661,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.cmi.2022.01.011","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T02:25:53Z","timestamp":1643855153000},"page":"1024.e7-1024.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neutralizing antibody activity against the B.1.617.2 (delta) variant 8\u00a0months after two-dose vaccination with BNT162b2 in health care workers"],"prefix":"10.1016","volume":"28","author":[{"given":"Louise","family":"Benning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Morath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin","family":"Reineke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"T\u00f6llner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Nusshag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"K\u00e4lble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Reichel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caner","family":"S\u00fcsal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudius","family":"Speer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.01.011_bib1","series-title":"WHO COVID-19 dashboard","year":"2021"},{"key":"10.1016\/j.cmi.2022.01.011_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cmi.2022.01.011_bib3","doi-asserted-by":"crossref","first-page":"691715","DOI":"10.3389\/fimmu.2021.691715","article-title":"Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern","volume":"12","author":"Deshpande","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2022.01.011_bib4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib5","article-title":"Clinical and genomic characterization of SARS CoV-2 infections in mRNA vaccinated health care personnel in New York City","author":"Robilotti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.01.011_bib6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41591-021-01413-7","article-title":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals","volume":"27","author":"Kustin","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib7","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib8","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-021-03693-y","article-title":"BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants","volume":"596","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2022.01.011_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2215\/CJN.03700321","article-title":"Early humoral responses of hemodialysis patients after COVID-19 vaccination with BNT162b2","volume":"16","author":"Speer","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2022.01.011_bib11","doi-asserted-by":"crossref","first-page":"721286","DOI":"10.3389\/fmed.2021.721286","article-title":"Humoral responses to single-dose BNT162b2 mRNA vaccination in dialysis patients previously infected with SARS-CoV-2","volume":"8","author":"Speer","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/vaccines9080857","article-title":"Heterologous ChAdOx1 nCoV-19\/BNT162b2 prime-boost vaccination induces strong humoral responses among health care workers","volume":"9","author":"Benning","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.cmi.2022.01.011_bib13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.kint.2021.07.002","article-title":"Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2","volume":"100","author":"Speer","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.cmi.2022.01.011_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A\u00a0SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cmi.2022.01.011_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0000000000003524","article-title":"Development and validation of a multiplex, bead-based assay to detect antibodies directed against SARS-CoV-2 proteins","volume":"105","author":"Bray","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2022.01.011_bib16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamapediatrics.2021.0001","article-title":"Prevalence of SARS-CoV-2 infection in children and their parents in Southwest Germany","volume":"175","author":"T\u00f6nshoff","year":"2021","journal-title":"Jama Pediatr"},{"key":"10.1016\/j.cmi.2022.01.011_bib17","first-page":"2021","article-title":"Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein","author":"Mallm","year":"2021","journal-title":"Medrxiv"},{"key":"10.1016\/j.cmi.2022.01.011_bib18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMc2113468","article-title":"SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3","volume":"385","author":"Falsey","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib19","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/s41423-021-00772-y","article-title":"Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance","volume":"18","author":"Arora","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cmi.2022.01.011_bib20","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMc2102017","article-title":"Neutralizing activity of BNT162b2-elicited serum","volume":"384","author":"Liu","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib21","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2022.01.011_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41591-021-01432-4","article-title":"A correlate of protection for SARS-CoV-2 vaccines is urgently needed","volume":"27","author":"Krammer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib24","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 vaccine booster against Covid-19 in Israel","volume":"385","author":"Bar-On","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cmi.2022.01.011_bib27","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.chom.2021.06.007","article-title":"Global COVID-19 vaccine inequity: the scope, the impact, and the challenges","volume":"29","author":"Asundi","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cmi.2022.01.011_bib28","doi-asserted-by":"crossref","first-page":"301.e1","DOI":"10.1016\/j.cmi.2021.09.016","article-title":"Humoral and cell-mediated response elicited by SARS-CoV-2 mRNA vaccine BNT162b2 e in healthcare workers: a longitudinal observational study","volume":"28","author":"Cassaniti","year":"2022","journal-title":"Clin Microbiol Infec"},{"key":"10.1016\/j.cmi.2022.01.011_bib29","first-page":"ciab915","article-title":"mRNA vaccine-elicited SARS-CoV-2-specific T cells persist at 6 months and recognize the delta variant","author":"Woldemeskel","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:30:37Z","timestamp":1761118237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X22000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1198743X22000350"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.01.011","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing antibody activity against the B.1.617.2 (delta) variant 8\u00a0months after two-dose vaccination with BNT162b2 in health care workers","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}